Anna Lyhne

Mar 5, 2024 | ejnmmires.springeropen.com | Kim Vang |Anna Lyhne |Mette Pedersen |Ole Munk |André H. Dias |Anna Johnsson | +10 more

The protocol received approval from the Danish Medicines Agency (2019083844) and Central Denmark Region Committees on Health Research Ethics (1-10-72-195-19). The study is registered in the European Union Drug Regulating Authorities Clinical Trials Database (EudraCT: 2019-002665-35). The study was monitored by the Good Clinical Practice unit at Aarhus and Aalborg University Hospitals. Written and oral informed consent from all participating individuals were obtained.